Study on Prevention, Treatment and Mechanism of Preterm Labor for Chinese Pregnant Women ≥35 Years Old
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03210415 |
|
Recruitment Status : Unknown
Verified October 2019 by Hongbo Qi, Ministry of Science and Technology of the People´s Republic of China.
Recruitment status was: Enrolling by invitation
First Posted : July 7, 2017
Last Update Posted : October 29, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Preterm Labor | Other: Observational Study Model |
| Study Type : | Observational |
| Estimated Enrollment : | 1500 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Study on Prevention, Treatment and Mechanism of Preterm Labor for Chinese Pregnant Women ≥35 Years Old |
| Actual Study Start Date : | August 1, 2017 |
| Estimated Primary Completion Date : | June 30, 2020 |
| Estimated Study Completion Date : | December 30, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Study group
Pregnant women ≥35 years old would have spontaneous preterm labor. There's no intervention in this group, because it's an Observational Study Model.
|
Other: Observational Study Model
There is no intervention for the study. |
|
Control group
Pregnant women ≥35 years old would not have spontaneous preterm labor. There's no intervention in this group, because it's an Observational Study Model.
|
Other: Observational Study Model
There is no intervention for the study. |
- Morbidity of Preterm birth [ Time Frame: 1 years ]Preterm delivery (PTD) is one of the most common and most serious complications of pregnancy. In China, preterm delivery is defined as delivery after 28 weeks completed but before 37 weeks of gestation. PTD rate varies between 5-18 %. Outcome also varies with the quality of neonatal care. create the highest burden for the society.
- Social Burden [ Time Frame: 1 years ]Outcome varies with the quality of neonatal care. create the highest burden for the society. A 2006 report from the Institute of Medicine estimated the annual cost of preterm birth in the United States to be $26.2 billion or more than $51,000 per premature infant .
- Morbidity of Chorioamnionitis [ Time Frame: 1 years ]The main hypothesis of the etiology of spontaneous PTD is ascending infection from the lower genital tract up in the sterile uterus invading the decidua, chorioamniotic membranes, amniotic fluid and, in some cases, the fetus. This is responsible for an inflammatory condition that might trigger myometrial contractions, rupture of the membranes and cervical maturation leading to PTD. Investigations have shown that the amount of bacteria present in the amniotic fluid is correlated to the level of intrauterine inflammation. Inflammation is also related to the presence of bacteria in the amniotic fluid and to histological chorioamnionitis.
- Respiratory distress syndrome, ischemic hypoxic encephalopathy, necrotizing enterocolitis, various infections [ Time Frame: 1 years ]the short-term outcomes of the preterm delivery, which will cost money, time and source to beat. The treatment is not satisfactory, but create the highest burden for the society.
- Cerebral palsy, chronic lung disease, blindness caused by retinopathy, auditory nerve abnormalities, mental retardation [ Time Frame: 1 years ]the long-term outcomes of the preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field.
Biospecimen Retention: Samples With DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 35 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | study on pregnant women |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Chinese pregnant women ≥ 35 years old
Exclusion Criteria:
- twins or multiple pregnancies, indicated preterm birth, <35 years old, gestational ages ≥ 37 weeks, incomplete data of prenatal care。
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03210415
| China, Chongqing | |
| The First Affilliated Hospital of Chongqig Medical University | |
| Chongqing, Chongqing, China, 400010 | |
| Principal Investigator: | Hongbo bo Qi, Dr. | First Affiliated Hospital of Chongqing Medical University |
| Responsible Party: | Hongbo Qi, Principle Investigator, Ministry of Science and Technology of the People´s Republic of China |
| ClinicalTrials.gov Identifier: | NCT03210415 |
| Other Study ID Numbers: |
2016YFC1000407 |
| First Posted: | July 7, 2017 Key Record Dates |
| Last Update Posted: | October 29, 2019 |
| Last Verified: | October 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Preterm Labor China Pregnant Women ≥35 Years Old |
|
Premature Birth Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications |

